A Pilot Study to Assess the Safety, Tolerability, and Tumor Responses with Lenvatinib Plus Pembrolizumab in Patients with Advanced Pancreatic Ductal Adenocarcinoma in Second-Line or Later Of
CANCER RESEARCH（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined